Associate Director, Business Development - Search & Evaluation

The role

The Associate Director of Business Development, Strategic Sourcing will evaluate and assess early-stage assets and opportunities for the business development pipeline. This cross-functional role involves collaborating with BD, R&D, Commercial, Tech, and Leadership teams to grow the asset portfolio.

What you will do

• Supporting deal-by-deal opportunity assessment teams from asset identification to transaction close.
• Collaborating with the BD team to identify target areas for outreach.
• Maximizing activity and ensuring high-quality support and diligence in strategic asset growth therapeutic areas and modalities.
• Evaluating market potential and risk based assessments of pipeline asset opportunities.
• Engaging with the broader diligence team to ensure strategic fit.
• Working cross-functionally with R&D, tech platform, and commercial teams.

Required qualifications

• 1-3 years of post-degree experience, with a combination of scientific and business expertise
• Ability to build strong relationships within the biotech and pharmaceutical industries
• Enthusiastic about networking, relationship building, and externally-facing activities
• An outgoing, motivated, and creative approach to business development
• Curiosity and insight around the role of AI in drug development, clinical trials, and business development

Nice to have

• PhD in biological science or MD with laboratory research experience
• Prior experience of biotech or pharmaceutical business development (search & evaluation), venture capital investing, or life sciences consulting

Benefits

• Equity
• Comprehensive benefits
• Generous perks

Before you apply

• Please apply only if you reside in New York City, Boston metro areas, Research Triangle (NC), or San Francisco Bay Area or are willing to relocate.

About the company

Formation Bio is a tech and AI driven pharma company that builds technology platforms, processes, and capabilities to accelerate drug development and clinical trials. The company partners, acquires, or in-licenses drugs to develop programs past clinical proof of concept.